NDC 50090-6744-01 - Clonidine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6744
- Requested NDC
- 50090-6744-01
- Package NDCs from labels
- 50090-6744-0, 50090-6744-1, 50090-6744-2, 50090-6744-7, 50090-6744-8, 50090-6744-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-10-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Clonidine Hydrochloride - A-S Medication Solutions | A-S Medication Solutions | 2024-10-08 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6744-0 | Clonidine Hydrochloride | 30 in 1 BOTTLE | TABLET | 30 | 6 | |
| 50090-6744-1 | Clonidine Hydrochloride | 60 in 1 BOTTLE | TABLET | 60 | 6 | |
| 50090-6744-2 | Clonidine Hydrochloride | 100 in 1 BOTTLE | TABLET | 100 | 6 | |
| 50090-6744-7 | Clonidine Hydrochloride | 90 in 1 BOTTLE | TABLET | 90 | 6 | |
| 50090-6744-8 | Clonidine Hydrochloride | 180 in 1 BOTTLE | TABLET | 180 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6744 | CLONIDINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS] | 6 | Current NDC, 5 package rows | 20241009_c7f473df-94ab-41db-8cc7-9a159d5e6dc4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6744-1 | EA - Each | 50090-6744 | 273ee024-63c6-4e5f-a4f3-e9d6a63317c2 | 1 | 2023-12-05 |
| 50090-6744-2 | EA - Each | 50090-6744 | 92f79324-d8bb-4a2a-b480-c6ae20785ba1 | 1 | 2023-12-05 |
| 50090-6744-7 | EA - Each | 50090-6744 | 59ce5974-e0a6-4178-9372-db8a3cde502f | 1 | 2023-12-05 |
| 50090-6744-8 | EA - Each | 50090-6744 | a6a4714b-896b-4046-b044-2f3c10e4f825 | 1 | 2023-12-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Refresh Optive Mega-3 PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | 326cb5d6-c784-404f-9a13-6d69262dda6e | 2026-03-01 | Warnings | 6OZP39ZG8H |
| Clonidine hydrochloride | CLONIDINE HYDROCHLORIDE | Bryant Ranch Prepack | a32f4b18-1090-4d79-a56b-39c0cf366bbc | 2026-02-05 | Warnings, Adverse reactions | 884185 W76I6XXF06 |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| clonidine hydrochloride | CLONIDINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 1ab3b82f-db7f-22bf-e063-6294a90ae93f | 2026-01-13 | Warnings, Adverse reactions | 884173 W76I6XXF06 |
| clonidine hydrochloride | CLONIDINE HYDROCHLORIDE | Northwind Health Company, LLC | ab2ffb6e-7070-063b-e053-2a95a90aff22 | 2026-01-01 | Warnings, Adverse reactions | 884189 W76I6XXF06 |
| Clonidine Hydrochloride | CLONIDINE HYDROCHLORIDE | Northwind Health Company, LLC | 66dc3cf0-d6bd-436c-9a7f-7477575b3260 | 2026-01-01 | Warnings, Adverse reactions | 884173 W76I6XXF06 |
| Clonidine hydrochloride | CLONIDINE HYDROCHLORIDE | Northwind Health Company, LLC | df603f27-d341-3957-e053-2995a90a825f | 2026-01-01 | Warnings, Adverse reactions | 884173 W76I6XXF06 |
| Clonidine hydrochloride | CLONIDINE HYDROCHLORIDE | Northwind Health Company, LLC | f30324be-47b6-7f54-e053-2995a90a3ad4 | 2026-01-01 | Warnings, Adverse reactions | 884189 W76I6XXF06 |
| Clonidine hydrochloride | CLONIDINE HYDROCHLORIDE | Northwind Health Company, LLC | df77e732-9765-ee5c-e053-2a95a90abc92 | 2026-01-01 | Warnings, Adverse reactions | 884185 W76I6XXF06 |
| Clonidine Hydrochloride | CLONIDINE HYDROCHLORIDE | Northwind Health Company, LLC | 18c873b1-f2fe-4ba9-b384-38e917af373b | 2026-01-01 | Warnings, Adverse reactions | 884185 W76I6XXF06 |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | O8232NY3SJ |
| Clonidine | CLONIDINE | Ingenus Pharmaceuticals, LLC | 99485427-a120-4fc7-bb61-25857d1900ec | 2025-12-05 | Warnings, Adverse reactions | W76I6XXF06 |
| Clonidine Hydrochloride | CLONIDINE HYDROCHLORIDE | BluePoint Laboratories | 1ea412db-d847-4094-be83-e3bd7328537a | 2025-11-04 | Warnings, Adverse reactions | 884185 884173 884189 W76I6XXF06 |
| clonidine hydrochloride | CLONIDINE HYDROCHLORIDE | VERITYRX, LLC | 42788adf-a54d-3545-e063-6394a90a8c69 | 2025-10-31 | Warnings, Adverse reactions | 884173 W76I6XXF06 |
| clonidine hydrochloride | CLONIDINE HYDROCHLORIDE | VERITYRX, LLC | 427939a4-6bbf-0d80-e063-6294a90aa2a0 | 2025-10-31 | Warnings, Adverse reactions | 884173 W76I6XXF06 |
| Clonidine hydrochloride | CLONIDINE HYDROCHLORIDE | Ajanta Pharma USA Inc. | df80255e-f942-4d9f-8edd-cc95795772cb | 2025-10-31 | Warnings, Adverse reactions | W76I6XXF06 |
| Clonidine Hydrochloride | CLONIDINE HYDROCHLORIDE | Bryant Ranch Prepack | 60171b1d-03af-4849-a030-6260192b11ce | 2025-10-29 | Warnings, Adverse reactions | 884189 W76I6XXF06 |
| JAVADIN | CLONIDINE HYDROCHLORIDE ORAL | Azurity Pharmaceuticals, Inc. | c36d94f5-a30d-4997-b141-e79a4ea45ecf | 2025-10-24 | Warnings, Adverse reactions | W76I6XXF06 |
| CLONIDINE HYDROCHLORIDE | CLONIDINE HYDROCHLORIDE | Proficient Rx LP | d072d601-b3d2-46e0-af1f-98adc9572f4a | 2025-10-01 | Warnings, Adverse reactions | 884173 W76I6XXF06 |
| Clonidine Hydrochloride | CLONIDINE HYDROCHLORIDE | Bryant Ranch Prepack | 5bc6188d-5b51-4dee-a12d-f2d5e42eb88d | 2025-09-18 | Warnings, Adverse reactions | 884185 W76I6XXF06 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.